Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result

NCT00146120 is registered in ClinicalTrials.gov with University of Ulm as lead sponsor.

NCT NCT00146120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00146120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result
Lead sponsor
University of Ulm
Phase
Phase 3
Overall status
Completed
Start date
May 31, 1998
Completion date
May 31, 2005
Enrollment
400
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia